Ivermectin for Triple-Negative Breast Cancer: Research, Regulation, and Legal Context
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptors, progesterone receptors, and HER2 […]





